INFINITT North America Expands Digital Pathology Portfolio with FDA-Cleared Hamamatsu S360MD Scanner Integration
recent articles
Why clearer, more actionable reports could drive wider AI adoption in diagnostics If you had asked Flora Abilova 20 years ago where she saw herself, she might have pictured a courtroom, arguing cases with the sharp precision of a seasoned...
WILMINGTON, Mass. and DUBLIN, Ireland—February 10, 2025—Charles River Laboratories International, Inc. (NYSE: CRL) and Deciphex, a leader in AI-powered digital pathology, today announced the next phase of a strategic collaboration to focus...
From the Lumea blog: Digital transformation is reshaping industries across the globe, and pathology is no exception. While much of the “dig path” buzz centers around the potential of artificial intelligence (AI) as a diagnostic aid,...
Learn how Tribun Health and Ibex are integrating AI-powered digital pathology to improve diagnoses, streamline workflows, and support pathologists globally. Artificial intelligence is gradually becoming a practical tool for healthcare,...
Harrison.ai: Company’s Radiology and Pathology Solutions Expand Clinician Capacity, Increase Operational Efficiency, and Improve Early Disease Diagnosis February 11, 2025 10:00 AM Eastern Standard Time BOSTON--(BUSINESS...
Ibex: FDA clearance affirms Ibex’s position as a global leader in AI-powered cancer diagnostics February 10, 2025 08:05 AM Eastern Standard Time BOSTON--(BUSINESS WIRE)--Ibex Medical Analytics (Ibex), the leader in...
